NCT07107204 2025-09-17
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
Biotroy Therapeutics
Phase 1/2 Not yet recruiting
Biotroy Therapeutics
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Assiut University